263 related articles for article (PubMed ID: 32019406)
1. Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study.
Jensen PN; Fretts AM; Hoofnagle AN; Sitlani CM; McKnight B; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N; Lemaitre RN
J Am Heart Assoc; 2020 Feb; 9(4):e012853. PubMed ID: 32019406
[TBL] [Abstract][Full Text] [Related]
2. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.
Bockus LB; Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
JAMA Netw Open; 2023 Nov; 6(11):e2343854. PubMed ID: 37976059
[TBL] [Abstract][Full Text] [Related]
3. Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk.
Lemaitre RN; Jensen PN; Hoofnagle A; McKnight B; Fretts AM; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N
Circ Heart Fail; 2019 Jul; 12(7):e005708. PubMed ID: 31296099
[TBL] [Abstract][Full Text] [Related]
4. Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study.
Fretts AM; Mozaffarian D; Siscovick DS; Djousse L; Heckbert SR; King IB; McKnight B; Sitlani C; Sacks FM; Song X; Sotoodehnia N; Spiegelman D; Wallace ER; Lemaitre RN
J Am Heart Assoc; 2014 Jun; 3(3):e000889. PubMed ID: 24970268
[TBL] [Abstract][Full Text] [Related]
5. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Howard BV; Umans JG; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
Cardiovasc Diabetol; 2022 Aug; 21(1):167. PubMed ID: 36042511
[TBL] [Abstract][Full Text] [Related]
6. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
[TBL] [Abstract][Full Text] [Related]
7. Plasma Ceramide Species Are Associated with Diabetes Risk in Participants of the Strong Heart Study.
Fretts AM; Jensen PN; Hoofnagle A; McKnight B; Howard BV; Umans J; Yu C; Sitlani C; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
J Nutr; 2020 May; 150(5):1214-1222. PubMed ID: 31665380
[TBL] [Abstract][Full Text] [Related]
8. Very long-chain saturated fatty acids and diabetes and cardiovascular disease.
Lemaitre RN; King IB
Curr Opin Lipidol; 2022 Feb; 33(1):76-82. PubMed ID: 34907969
[TBL] [Abstract][Full Text] [Related]
9. Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study.
Lemaitre RN; Fretts AM; Sitlani CM; Biggs ML; Mukamal K; King IB; Song X; Djoussé L; Siscovick DS; McKnight B; Sotoodehnia N; Kizer JR; Mozaffarian D
Am J Clin Nutr; 2015 May; 101(5):1047-54. PubMed ID: 25787996
[TBL] [Abstract][Full Text] [Related]
10. Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
Clin Chem; 2021 Nov; 67(12):1650-1659. PubMed ID: 34580702
[TBL] [Abstract][Full Text] [Related]
11. Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Howard BV; Umans J; Sitlani CM; Siscovick DS; King IB; Djousse L; Sotoodehnia N; Lemaitre RN
J Lipid Res; 2021; 62():100119. PubMed ID: 34555371
[TBL] [Abstract][Full Text] [Related]
12. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
[TBL] [Abstract][Full Text] [Related]
14. Serum androgens and risk of atrial fibrillation in older men: The Cardiovascular Health Study.
Rosenberg MA; Shores MM; Matsumoto AM; Bůžková P; Lange LA; Kronmal RA; Heckbert SR; Mukamal KJ
Clin Cardiol; 2018 Jun; 41(6):830-836. PubMed ID: 29671886
[TBL] [Abstract][Full Text] [Related]
15. Divergent fate of unsaturated and saturated ceramides and sphingomyelins in rat liver and cells in culture.
Stein O; Oette K; Hollander G; Dabach Y; Ben-Naim M; Stein Y
Biochim Biophys Acta; 1989 Jun; 1003(2):175-82. PubMed ID: 2730890
[TBL] [Abstract][Full Text] [Related]
16. Associations of plasma phospholipid and dietary alpha linolenic acid with incident atrial fibrillation in older adults: the Cardiovascular Health Study.
Fretts AM; Mozaffarian D; Siscovick DS; Heckbert SR; McKnight B; King IB; Rimm EB; Psaty BM; Sacks FM; Song X; Spiegelman D; Lemaitre RN
J Am Heart Assoc; 2013 Jan; 2(1):e003814. PubMed ID: 23525429
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.
Mielke MM; Haughey NJ; Han D; An Y; Bandaru VVR; Lyketsos CG; Ferrucci L; Resnick SM
J Alzheimers Dis; 2017; 60(3):819-828. PubMed ID: 28035934
[TBL] [Abstract][Full Text] [Related]
18. Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).
Norby FL; Tang W; Pankow JS; Lutsey PL; Alonso A; Steffen BT; Chen LY; Zhang M; Shippee ND; Ballantyne CM; Boerwinkle E; Coresh J; Folsom AR
Am J Cardiol; 2021 Dec; 161():42-50. PubMed ID: 34794617
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Njølstad I; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Mathiesen E; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
Circulation; 2017 Oct; 136(17):1588-1597. PubMed ID: 29038167
[TBL] [Abstract][Full Text] [Related]
20. Individual non-esterified fatty acids and incident atrial fibrillation late in life.
Pellegrini CN; Buzkova P; Lichtenstein AH; Matthan NR; Ix JH; Siscovick DS; Heckbert SR; Tracy RP; Mukamal KJ; Djoussé L; Kizer JR
Heart; 2021 Nov; 107(22):1805-1812. PubMed ID: 33483356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
